EKF Diagnostics Holdings Plc (EKF)

Currency in GBP
29.40
-0.90(-2.97%)
Closed·
EKF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
EKF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.2029.80
52 wk Range
18.4031.20
Key Statistics
Bid/Ask
29.40 / 29.80
Prev. Close
30.3
Open
29.8
Day's Range
29.2-29.8
52 wk Range
18.4-31.2
Volume
344.3K
Average Volume (3m)
408.61K
1-Year Change
13.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EKF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
33.33
Upside
+13.38%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

EKF Diagnostics Holdings Plc Company Profile

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes; and STAT-Site W Beta-Hydroxybutyrate analyzer. In addition, the company offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; Lactate Scout Vet, a handheld lactate analyzer for veterinary care; Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer; Lactate Scout Sport, a lactate analyzer for sports performance; Biosen series for sports; and EKF Link, a data management solution that integrates point-of-care analyzers. Further, it offers Beta-Hydroxybutyrate LiquiColor for monitoring ketosis; RaPET, a range of immunoassay kits; QuStick Strep A for Strep A infection treatment; Hema-Screen Lab Pack for detection of colorectal cancer; PrimeStore MTM, a molecular transport medium that preserves and stabilizes DNA and RNA; Uri-Trak 120M urine analyzer; and clinical chemistry reagents, controls, and standards. Additionally, the company provides precision fermentation, custom bioprocessing, and contract manufacturing solutions; and diagnostic enzymes that include arylacylamidase, beta-hydroxybutyrate dehydrogenase, and salicylate hydroxylase. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.

Compare EKF to Peers and Sector

Metrics to compare
EKF
Peers
Sector
Relationship
P/E Ratio
21.3x−3.4x−0.5x
PEG Ratio
0.130.010.00
Price/Book
1.8x1.5x2.6x
Price / LTM Sales
2.6x3.6x3.3x
Upside (Analyst Target)
12.2%81.4%43.5%
Fair Value Upside
Unlock21.0%6.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 33.33
(+13.38% Upside)

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.01 / 0.008
Revenue / Forecast
24.98M / 27.70M
EPS Revisions
Last 90 days

EKF Income Statement

FAQ

What Stock Exchange Does EKF Diagnostics Trade On?

EKF Diagnostics is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for EKF Diagnostics?

The stock symbol for EKF Diagnostics is "EKF."

What Is the EKF Diagnostics Market Cap?

As of today, EKF Diagnostics market cap is 132.12M.

What Is EKF Diagnostics's Earnings Per Share (TTM)?

The EKF Diagnostics EPS (TTM) is 0.01.

When Is the Next EKF Diagnostics Earnings Date?

EKF Diagnostics will release its next earnings report on 15 Sept 2025.

From a Technical Analysis Perspective, Is EKF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has EKF Diagnostics Stock Split?

EKF Diagnostics has split 1 times.

How Many Employees Does EKF Diagnostics Have?

EKF Diagnostics has 303 employees.

What is the current trading status of EKF Diagnostics (EKF)?

As of 05 Aug 2025, EKF Diagnostics (EKF) is trading at a price of 29.40, with a previous close of 30.30. The stock has fluctuated within a day range of 29.20 to 29.80, while its 52-week range spans from 18.40 to 31.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.